U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07545434) titled 'The Prognostic Role of TILs and CD8+ T Cells in Operable Breast Cancer' on March 20.
Brief Summary: T cells are a broad class of adaptive immune cells, while CD8⁺ T cells are a specific, specialized subset of T cells, defined by the presence of the CD8 surface receptor. T cells, matured in the thymus, consist of helper, cytotoxic and regulatory functions.
This study aimed to evaluate the clinical importance of Tumor Infiltrating Lymphocytes (TILs) as well as CD8⁺ T cells in patients with early-stage breast cancer (eBC) treated with dose-dense sequential chemotherapy.
The researchers aim to assess tumor samples for TIL...